Clinical application · Document 09

The Veteran Mental Health and Resilience Restoration Protocol

Nutraceutical Assisted Programs

A Reference Protocol of the NAP Standards Library Veteran Health Specialty · Protocol VH-01 The First Published Exemplar of a Complete NAP Protocol Michael Andrew Feller Jones Founder, Nutraceutical Assisted Programs Category

About This Protocol

This is the first complete protocol published to the NAP Standards Library, and it is offered as the reference exemplar of what every NAP protocol looks like: a forensic assessment, a terrain-first phased restoration sequence, condition-specific intervention, somatic and spiritual integration, community reintegration, defined outcome measurement, and explicit safety governance — all interoperating with conventional care.

It is written at the standards level. It specifies the clinical logic, the sequence, the intervention classes, the clinical targets, the outcome instruments, and the safety rules. It does not specify proprietary formulations or fixed doses. Agent selection, dosing, and titration are individualized by the credentialed NAP practitioner for the specific patient, within the safety boundaries defined here. This is a clinical framework, not a prescription, and not medical advice.

It is also a mental health protocol for a population at elevated risk of suicide. Crisis safety governs everything that follows. A veteran in crisis is stabilized first; restoration proceeds second.

Veterans Crisis Line: dial 988, then press 1 · text 838255 · VeteransCrisisLine.net

PART I. SCOPE AND PRINCIPLES

1. Clinical Scope and Indication

This protocol addresses the veteran mental health symptom cluster — post-traumatic stress, depression, anxiety, suicidal ideation, the cognitive and mood sequelae of traumatic brain injury, substance use disorder, sleep collapse, and the chronic pain that so often accompanies them — as the surface expression of an underlying, multi-system biological cascade, per the NAP Veteran Health Specialty Track.

It is indicated for veterans and active service members presenting with one or more of these conditions, particularly where conventional pharmaceutical management has produced incomplete or non-durable results. It is designed to be delivered alongside VA, military, and community mental health care, never as a replacement for it, and it is explicitly aligned with the VA Whole Health model and PACT Act toxic-exposure recognition.

It is not a stand-alone treatment for acute psychiatric emergency. Active suicidal crisis, acute psychosis, acute intoxication or withdrawal, and acute medical instability are stabilized through emergency and conventional channels first.

2. Foundational Principles

This protocol operationalizes the principles of the NAP Manifesto in a single population.

Terrain before intervention. The biological substrate is assessed and restored before, and underneath, symptom-directed work.
Cascade-aware sequencing. The five pillars of the veteran cascade — toxic burden, microbial and barrier disruption, mineral and essential fatty acid depletion, hormonal dysregulation, and pharmaceutical iatrogenesis — are addressed in an order that prevents harm and compounds benefit.
Natural first, pharmaceutical when necessary. Pharmaceuticals remain available and appropriate; de-prescribing, where indicated, is gradual and supervised.
The patient is a system. Body, brain, spirit, family, and community are treated as one.
Function over perfection. Progress is measured by restored capacity, not by the elimination of every symptom.

PART II. SAFETY AND ASSESSMENT

3. Phase Zero — Crisis Safety and Medical Baseline

No restorative work begins until Phase Zero is complete.

Crisis and suicide-risk screening. Every patient is screened at intake and at defined intervals with a validated suicide-risk instrument (for example, the Columbia Suicide Severity Rating Scale). Any active risk triggers the crisis pathway: the Veterans Crisis Line, coordination with the patient's mental health provider, a safety plan, and emergency referral where indicated. Restoration is paused, not abandoned, during acute crisis.

Medical baseline and contraindication screening. A complete current medication list, medical and psychiatric history, pregnancy status where applicable, and hepatic, renal, cardiac, and metabolic status are established before any intervention. Conditions that modify or contraindicate specific interventions are flagged here.

Coordination of care. The patient's existing prescribers are identified and, with consent, engaged. This protocol is delivered in coordination with conventional care, and any future de-prescribing is theirs to authorize and supervise.

Absolute safety rules. (1) No psychiatric or other medication is reduced or discontinued without the supervising prescriber's authorization. (2) No toxic-burden mobilization is undertaken before drainage capacity and microbial and barrier integrity are established (see Phase Four). (3) No intervention proceeds against a known contraindication. (4) Crisis stabilization always supersedes the restoration sequence.

4. Assessment — The Five-Component Veteran Assessment Protocol

Assessment follows the standardized Veteran Assessment Protocol of the Specialty Track, completed across the first two to four encounters:

Exposure history — the cumulative environmental and service exposure timeline.
Symptom and functional history — the temporal progression of the presentation, mapped against exposures and pharmaceutical initiation.
Pharmaceutical burden inventory — every medication, current and historical, to inform later supervised de-prescribing.
Biomarker panel — toxic burden, microbial and barrier markers, comprehensive mineral and nutrient status, essential fatty acid status (omega-3 index), inflammatory markers, full hormonal panel, and standard metabolic, hepatic, renal, and lipid chemistry.
Functional and psychological assessment — validated instruments establishing the functional baseline: PCL-5 (post-traumatic stress), PHQ-9 (depression), GAD-7 (anxiety), a cognitive screen where TBI is present, AUDIT or DAST for substance use, and sleep, pain, quality-of-life, purpose, and community-engagement measures.

These five components integrate into a single map of the individual's cascade, which sequences everything that follows.

PART III. THE PHASED RESTORATION SEQUENCE

The restoration sequence is the heart of the protocol. Each phase has an objective, defined clinical targets, intervention classes, safety boundaries, and tracked outcomes. The phases overlap rather than occur in strict isolation, and the sequence is governed by one principle: the body is made safe and resourced before it is asked to release burden or process trauma. Agent selection and dosing within each class are individualized by the credentialed practitioner.

5. Phase One — Create Safety and Calm the Nervous System

Cornerstones One and Three. Objective: shift the veteran out of chronic sympathetic activation and restore the sleep on which all repair depends.

Clinical targets: autonomic regulation, sleep architecture, acute anxiety load.
Intervention classes: magnesium and glycine repletion for nervous-system regulation and sleep; calming botanical classes (for example, adaptogenic and nervine herbs) selected to patient presentation; circadian and sleep-hygiene restructuring; breathwork and parasympathetic-activating somatic practice from Cornerstone Three.
Safety: screen for interactions with sedating medications; coordinate with any prescribed sleep agents.
Tracked: sleep quality and duration, GAD-7, subjective regulation.

6. Phase Two — Replenish the Foundational Substrate

Cornerstone One. Objective: restore the raw materials the brain and nervous system are built from and run on. This phase often produces the first durable symptomatic improvement.

Clinical targets: mineral status (magnesium, zinc, selenium, iodine, and ratio balance), essential fatty acid status (raising the omega-3 index, lowering the omega-6 to omega-3 ratio), B-vitamin complex, vitamin D.
Intervention classes: bioavailable mineral repletion with attention to antagonist pairs; clinical-grade EPA and DHA repletion (third-party tested for purity, given that some marine products themselves carry metal contamination); methylated B-vitamins where indicated; vitamin D restoration.
Rationale and calibration: essential fatty acid status is a structural substrate of the brain, and low DHA status has been associated with elevated suicide risk in active-duty service members (an association, not proof of causation; see the Evidence Compendium). Repletion is foundational substrate restoration, not a stand-alone antidepressant claim.
Tracked: serial mineral and omega-3 index testing; PHQ-9; energy and cognition.

7. Phase Three — Repair the Gut and Restore the Barrier

Cornerstone One. Objective: restore the absorptive surface and the barrier whose failure drives neuroinflammation, so that everything replenished in Phase Two can actually be absorbed and the inflammatory load on the brain falls.

Clinical targets: microbial balance, intestinal barrier integrity, where indicated parasitic and fungal clearance.
Intervention classes: antimicrobial and antiparasitic botanical protocols where the assessment indicates; biofilm and barrier-repair nutrient classes; microbiome restoration through targeted probiotics, prebiotic and fermented foods; dietary modification.
Safety: parasitic clearance and toxic-burden mobilization are coordinated, never run in conflict (see Phase Four); monitor for die-off reactions and adjust pace.
Tracked: digestive function, intestinal-permeability and inflammatory markers, cognitive and mood response via the gut–brain axis.

8. Phase Four — Reduce Toxic Burden

Cornerstone One. Objective: lower the accumulated toxic and heavy-metal load that drives the cascade — at a rate the body can safely bind and eliminate.

The cardinal safety rule: burden is never mobilized faster than drainage and binding capacity allow, and never before microbial and barrier integrity (Phase Three) are established, because mobilizing stored metals into a compromised gut re-circulates them and can worsen the patient. Mobilization is paired with binding and with microbial clearance, not run in isolation.
Intervention classes: drainage-pathway optimization (hepatic, renal, lymphatic, bowel) first; natural binding agents; cofactor support for the body's own detoxification pathways; staged, monitored mobilization only after drainage is open.
Safety: contraindicated or modified in pregnancy, significant renal or hepatic impairment, and other flagged conditions; serial testing detects redistribution events requiring a change of pace.
Tracked: serial toxic-burden testing, symptom response, tolerance.

9. Phase Five — Restore Cellular Energy

Cornerstones One and Two. Objective: restore mitochondrial function and metabolic flexibility, lifting the fatigue and exercise intolerance that block engagement with the rest of the protocol.

Clinical targets: mitochondrial function, oxidative-stress load, metabolic flexibility.
Intervention classes: mitochondrial cofactor support; oxidative-stress reduction; graded movement and recovery; dietary pattern toward metabolic flexibility.
Tracked: energy, exercise tolerance, metabolic markers.

10. Phase Six — Restore Hormonal and Metabolic Function

Cornerstones One and Two. Objective: restore the endocrine signaling that governs mood, drive, sleep, and metabolism, much of which improves on its own once the prior phases are complete.

Clinical targets: HPA-axis and cortisol rhythm, thyroid, sex hormones, insulin and metabolic markers.
Intervention classes: adaptogenic and botanical endocrine support matched to the dysfunctional axis; cofactor optimization; sleep and resistance-training support for endogenous hormone production; where natural support is insufficient, bioidentical hormone therapy through a qualified prescriber as a NAP-compatible intervention.
Rationale: sleep restoration alone measurably raises testosterone, so this phase builds directly on Phase One.
Tracked: serial hormonal panels; mood, drive, body composition.

11. Phase Seven — Restore the Brain and Process the Trauma

Cornerstones Two and Three. Objective: with the substrate now restored, support neurological regeneration and undertake the trauma-processing work that could not consolidate on a collapsing terrain.

Clinical targets: neuroinflammation, neuroregeneration and neuroplasticity, neurotransmitter substrate, the trauma itself.
Intervention classes: neuro-supportive and nootropic botanical classes; anti-inflammatory neuroprotection; the structured somatic and trauma-resolution modalities of Cornerstone Three (breathwork, meditation and yoga nidra, sound and vibrational practice, structured emotional processing); and, where lawful and clinically supervised, the wraparound infrastructure for psychedelic-assisted therapy. The order matters: the breakthroughs of trauma and psychedelic work fade without the restored biological substrate to consolidate them, which is why this phase follows rather than precedes terrain restoration.
Tracked: PCL-5, cognitive measures, durability of gains.

12. Phase Eight — Reintegration, Purpose, and Community

Cornerstone Four. Objective: restore the belonging, mission, and meaning whose loss is itself a clinical condition, and without which biological gains relapse in isolation.

Intervention classes (prescribed, tracked): structured peer community; mentorship; service projects; intergenerational engagement; purpose-discovery work; spiritual community honoring the patient's tradition or supporting its discovery; and family-system repair, recognizing that the family served too.
Tracked: purpose, community-engagement, and quality-of-life measures alongside the biomedical outcomes.

PART IV. ADAPTATION, INTEGRATION, AND OUTCOMES

13. Condition-Specific Layers

The phased sequence is the shared spine. The dominant presentation tunes the emphasis, not the foundation:

Post-traumatic stress: heavier investment in Phase One regulation and Phase Seven somatic and trauma processing.
Depression and suicidality: priority on Phase Two essential fatty acid and mineral restoration and Phase One sleep, with continuous crisis monitoring.
Traumatic brain injury: emphasis on Phase Five energy and Phase Seven neuroregeneration and neuroinflammation.
Substance use disorder: integration with addiction care, with Phases One through Four reducing the biological drivers of use and Phase Eight rebuilding the life that sustains recovery.

14. Integration with Conventional Care and Supervised De-Prescribing

This protocol interoperates with VA, military, and community care. Where the pharmaceutical burden inventory and restoration progress indicate, de-prescribing is gradual, monitored, and authorized and supervised by the prescribing clinician — never abrupt, never unilateral, and always with supportive substrate in place. The goal is not the absence of medication; it is the restoration of the terrain to the point where the underlying need for a given medication diminishes, as judged by the prescriber.

15. Outcome Measurement

Outcomes are tracked on a defined schedule and reported in functional terms.

Validated instruments re-administered at set intervals: PCL-5, PHQ-9, GAD-7, the suicide-risk instrument, and sleep, pain, and quality-of-life measures.
Biomarkers re-tested to confirm restoration: mineral status, omega-3 index, inflammatory markers, hormonal and metabolic panels, and toxic-burden markers.
Functional milestones: sleep restored, energy returned, drive and cognition recovered, relationships and purpose re-engaged.
Definition of response: restored capacity to live, work, connect, and find meaning — function over the elimination of every symptom.

Outcome data, de-identified and consented, feeds the NAP outcome registry, where it refines this protocol and builds the evidence base the framework calls for.

PART V. EVIDENCE AND SAFETY

16. Evidence Basis and Calibration

The mechanisms this protocol acts on are documented link by link and are consolidated, classified by strength, and cited in the NAP Evidence Compendium. What is not yet proven — and what this protocol states plainly — is the integrated cascade as a unified clinical hypothesis and the comparative effectiveness of this comprehensive sequence against single-intervention care. Those are precisely the questions the NAP outcome registry exists to answer. This protocol is therefore offered as a structured, evidence-informed, falsifiable clinical model, not as a closed finding. Associations are labeled as associations; the essential fatty acid and suicide-risk relationship in particular is presented as the case-control association the evidence supports, not as a prevalence claim.

17. Safety, Contraindications, and Scope of Practice

This protocol is delivered only by a credentialed NAP practitioner holding the Veteran Health Specialty, working within scope and in coordination with the patient's medical and mental health providers.
Crisis stabilization supersedes restoration at every point.
Toxic-burden mobilization follows the cardinal safety rule (Phase Four) without exception.
De-prescribing is prescriber-authorized and supervised.
Specific contraindications — pregnancy and lactation, significant renal or hepatic impairment, drug–nutrient and drug–botanical interactions, and others surfaced at medical baseline — modify or exclude specific interventions.
Agent selection and dosing are individualized by the practitioner; this document defines structure and boundaries, not prescriptions.

CLOSING

This is what a NAP protocol looks like: forensic before it is therapeutic, sequenced before it is aggressive, measured before it is declared successful, and safe before it is anything at all. It treats the veteran's mental health crisis as the biological and human event it is — and it restores, in order, the terrain, the brain, and the life.

It is the first protocol of the NAP Standards Library. Others, across every clinical territory and every population, follow this same shape.

Veterans Crisis Line: dial 988, then press 1 · text 838255 · VeteransCrisisLine.net

Suggest a change to this document Become a contributor